Peter DeMuth insider trades

Open-market stock purchases and sales by Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics, Inc, from SEC Form 4 filings since Feb 1, 2024.

Recent trades

DateStockTradeValue
Jul 16, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Feb 2, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Feb 2, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Dec 9, 2025ELTX Elicio Therapeutics, IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Jul 16, 2026

Get free alerts when Peter DeMuth files a new trade →